Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Enanta Pharmaceuticals Inc. - news published 239 - readings 3.959

BACK

Enanta Pharmaceuticals Inc.

Proxy Results, Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As disclosed below under Item 5.07, on March 13, 2025, the stockholders of Enanta Pharmaceuticals, Inc. approved an amendment to its 2019 Equity Incentive Plan to increase the number of shares reserved for issuance thereun ...

17.03.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSIO ...

14.03.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enanta Pharmaceuticals Inc. published this content on March 12, 2025 , and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 12, 2025 at 12:52:36.642 .

12.03.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.02.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.02.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.02.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.02.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.02.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.02.2025

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

13.02.2025

Enanta Pharmaceuticals Inc. - news published 239 - readings 3.959

Enanta Pharmaceuticals Inc.

Proxy Results, Management Change/Compensation (Form 8-K)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enanta Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member